This guide is designed for SPD managers, compliance officers, and perioperative directors who need a fast, structured self-assessment of their department's compliance posture. Each question maps to a real regulatory or accreditation standard. A "red flag" in any area warrants immediate review before your next TJC survey or state inspection.
Questions are aligned with AAMI ST79:2017, AAMI ST91:2021, TJC Infection Control standards, CMS Conditions of Participation, HSPA 9th Edition, and the October 2026 CHL Pilot Exam competency framework.
Core Operations
Over 20 U.S. states have enacted or are actively passing SPD technician certification mandates. Non-compliance is a direct regulatory violation, creating exposure to state health department citations, CMS CoP deficiencies, and — in some states — operating license risk. The certification landscape is evolving rapidly: states that had no mandate in 2022 may require certification by 2026.
The department maintains a certification tracking matrix showing each technician's certification body (HSPA CRCST, CBSPD, etc.), certification date, expiration, and state-required renewal deadlines. The manager conducts quarterly compliance reviews and has a documented plan for any uncertified staff — including exam enrollment dates and study support.
More than one technician is uncertified past your state's compliance deadline with no documented plan for achieving certification.
AAMI ST79:2017 mandates that all reprocessing follow the manufacturer's Instructions for Use (IFU). TJC surveyors routinely ask to see IFU documentation during IC surveys. Processing instruments without IFUs — especially loaner instruments and newly acquired devices — creates both regulatory and patient safety risk. Incompatible sterilization methods can damage instruments or fail to achieve adequate sterility.
The department maintains a living IFU library — physical or digital — indexed to the instrument inventory. Loaner instruments are never processed without IFUs in hand. New instruments trigger an IFU acquisition and workflow review before clinical deployment. Staff can articulate the IFU location for any instrument they are currently processing.
Technicians cannot locate the IFU for a commonly used instrument set when asked by a surveyor — or report that IFUs "are not routinely consulted."
First-pass yield (FPY) — the percentage of instrument sets that flow through the entire processing cycle without rework — is a composite indicator of processing quality. A low FPY signals problems across cleaning, inspection, assembly, packaging, or sterilization. TJC and CMS expect facilities to measure, trend, and act on quality metrics; inability to report FPY data suggests an absence of quality monitoring.
FPY is measured weekly, reported on the department's quality dashboard, and trended monthly. When FPY drops below the facility benchmark (typically >95%), a structured root cause analysis is triggered. Improvement projects are tracked with measurable outcomes and reported to the quality committee quarterly.
The department cannot state its current FPY or has never calculated it — indicating a quality monitoring gap that TJC will flag.
Biological indicators are the gold standard for verifying sterilization efficacy. AAMI ST79:2017 requires minimum daily BI testing per sterilizer, with every implant load requiring a BI (and quarantine until results confirm). Inadequate BI frequency means sterilization failures may go undetected. An undefined positive BI protocol means staff don't know what to do when a failure occurs — risking patient exposure.
A documented BI monitoring policy specifies daily minimum frequency, mandatory use in every implant load, flash sterilization cycle monitoring, and step-by-step positive BI response protocol: immediate quarantine of the load, investigation, recall if items were distributed, patient notification assessment, corrective action documentation, and sterilizer re-qualification before return to service.
BIs are run "when we remember" rather than on a defined schedule, or staff cannot describe what to do when a BI returns positive.
Standards Compliance
Occasionally, a manufacturer's IFU may conflict with AAMI standards or the facility's equipment capabilities (e.g., an instrument requiring 55°C wash when facility washers run at 65°C). Without a documented decision process, staff default to convenience — processing the instrument incorrectly and creating both patient safety and regulatory risk. This scenario is increasingly common with complex specialty instruments.
A documented IFU conflict resolution protocol requires: contacting the manufacturer for clarification, escalating to infection control and risk management for complex conflicts, applying the most restrictive standard when evidence is unclear, and documenting the decision with rationale. Exceptions to standard practice require documented manager approval and periodic review.
No documented IFU conflict process exists and technicians are expected to resolve conflicts independently without escalation guidance.
Loaner instrument management is one of the most frequently cited deficiencies in TJC and CMS surveys. Instruments arriving without IFUs, late deliveries processed without adequate lead time, or vendor-sterilized loaner instruments accepted for immediate use without reprocessing are all direct standards violations. Each year, MDRO outbreaks are linked to inadequately processed loaner implant systems.
A loaner instrument policy specifies: minimum advance delivery requirement (typically 24+ hours), mandatory IFU receipt before processing, inventory verification against delivery manifest, complete reprocessing regardless of vendor assurances, documentation of processing for every set, and vendor credentialing requirements. The policy is enforced consistently, including with high-volume or high-status vendors.
Vendor-sterilized loaner instruments are occasionally accepted for use without facility reprocessing because "the vendor guarantees they are sterile."
Reprocessing single-use devices (SUDs) is governed by FDA regulations that require FDA-cleared third-party reprocessors for most devices. Unauthorized SUD reprocessing creates patient safety risk (the device was not validated for multiple uses), FDA compliance violations, and potential product liability exposure. This is a frequently misunderstood area where well-intentioned cost-saving creates significant regulatory risk.
A documented SUD policy prohibits unauthorized reprocessing of FDA-labeled SUDs and specifies: approved third-party reprocessors for permitted devices, devices cleared for in-house reprocessing, and clear labeling/tracking requirements. Staff understand that "SUD" labeling is not always a technical limitation — some devices labeled SUD are reprocessed clinically — but that the regulatory process for doing so must be followed.
Staff are reprocessing SUD-labeled items in-house without FDA-cleared third-party involvement or documented facility policy authorization.
Staffing & Competency
Understaffed SPD departments are consistently identified as a root cause in infection outbreak investigations, sterilization failures, and instrument availability crises. HSPA benchmarking data shows that approximately 2–3 minutes of SPD processing time is required per OR minute — a ratio most facilities struggle to maintain. Chronic understaffing drives shortcuts, overtime fatigue, and staff turnover that compounds the problem.
The SPD manager has a documented FTE calculation based on case volume data, average processing time per instrument set, and shift structure. Current staffing is compared to the calculated requirement quarterly. Gaps are documented with a business case submitted to administration. Volume increases (new service lines, OR expansion) trigger a staffing reassessment.
The manager cannot cite a staffing benchmark or has never formally calculated FTE requirements based on case volume data.
TJC Human Resources standards require annual competency validation for all clinical staff, including SPD technicians. Written tests alone are insufficient — critical tasks must be validated through direct observation or skills demonstration. Undocumented competency creates a gap that surveyors will identify, and is often the root cause cited in post-event investigations when a processing error caused patient harm.
A competency validation program includes annual skills demonstration for: sterilizer operation and BI handling, complex instrument assembly (highest-risk sets), HLD procedures if applicable, and documentation processes. Results are recorded in each employee's personnel file. Competency gaps trigger a corrective education plan with re-validation before independent practice resumes.
Annual competency consists only of an online module quiz with no hands-on skills observation — particularly for sterilizer operation and high-risk instrument assembly.
HSPA's Certified Healthcare Leader (CHL) pilot examination launches October 2026, specifically targeting SPD managers and supervisors. Early-adopting states are already discussing CHL as a future supervisory requirement. The competency framework covers strategic leadership, quality management, financial literacy, and regulatory compliance — areas that many operationally-focused SPD supervisors have not formally studied.
SPD supervisors and managers are enrolled in CHL preparation programs, reviewing the HSPA Leadership Competency Framework, and completing structured study of the four CHL domains: strategic thinking, people leadership, quality and patient safety, and business/financial acumen. The facility supports CHL exam fees as part of leadership development investment.
SPD supervisors are unaware of the CHL examination or believe that existing CRCST certification satisfies emerging supervisory credential requirements.
Technology & Traceability
Instrument traceability — linking each instrument set to patient procedures, processing records, and sterilization lot data — is increasingly required by accreditation bodies and is essential for effective recall management when sterilization failures occur. Without tracking, a facility cannot determine which patients were exposed to a potentially non-sterile instrument, making patient notification impossible and liability exposure unlimited.
An instrument tracking system — paper-based at minimum, electronic preferred — links each processed set to: the sterilizer load, BI/CI results, technician ID, and patient case. Sterilization records are retained per facility policy (typically 10+ years for implants). The system enables a complete lookback within 24 hours of a failure notification.
A sterilization recall is initiated and the department cannot identify within 48 hours which patients received items from the affected load.
AAMI ST91:2021 significantly revised endoscope reprocessing requirements following duodenoscope-associated CRE outbreaks that affected hundreds of patients across the U.S. Non-compliance with ST91 — particularly around leak testing, channel brushing sequences, AER water quality monitoring, and vertical storage — remains the single greatest infection risk in many GI and pulmonary procedure units.
Endoscope reprocessing follows a documented protocol aligned with AAMI ST91:2021: mandatory pre-cleaning leak test, IFU-directed channel brushing with correct brush sizes, HLD agent MEC verification before each use, AER water quality monitoring, 70% IPA channel flush, vertical storage in a ventilated cabinet with port caps removed, and complete processing documentation linking scope ID to patient. Duodenoscopes receive enhanced protocols per FDA guidance.
Endoscopes are stored horizontally in sealed bags, or AER water filter maintenance logs show overdue filter changes with no corrective action.
Quality & Risk Management
Manufacturers update IFUs in response to new evidence, regulatory requirements, or post-market safety signals. A facility unaware of an updated IFU may continue a processing practice that is no longer validated — or more urgently, may miss a safety recall or reprocessing correction notice. Instrument distributors and manufacturers are not required to proactively notify every customer of IFU updates.
The department subscribes to manufacturer notification programs and FDA MedWatch alerts for key instrument categories. The IFU library is reviewed annually for updates, with high-risk/high-volume instruments reviewed more frequently. When an IFU update is identified, a change impact assessment is conducted, staff training is completed before the updated protocol is implemented, and the IFU library is updated with the new version and date.
The IFU library contains printed documents with no version tracking — it cannot be confirmed when IFUs were last verified as current.
Sterility breaches — positive biological indicators, packaging failures, process deviations — are sentinel events when they result in patient harm. TJC requires a rigorous root cause analysis (RCA) for sentinel events, and expects that RCA findings translate into durable corrective action. Without a structured RCA process, sterilization failures recur, liability accumulates, and the same preventable events happen repeatedly.
A documented sterilization failure response protocol defines trigger criteria, immediate quarantine steps, RCA methodology (5 Whys, fishbone, or FMEA), corrective action plan requirements (specific actions, owners, deadlines, measurable outcomes), and reporting to quality/risk management. RCA results are presented at quality committee and tracked for corrective action completion.
When a positive BI occurred last year, the investigation concluded with "technician error" and retraining — with no system-level corrective action or outcome metric to verify recurrence prevention.
AAMI ST79:2017 specifies that sterile storage areas should maintain temperature ≤75°F (24°C) and relative humidity 35–70% to preserve packaging integrity and sterility. Excessive humidity accelerates packaging material degradation and creates condensation that can compromise sterile barriers. TJC surveyors ask for temperature and humidity monitoring logs during IC surveys — missing logs are a consistent deficiency finding.
Temperature and humidity are monitored continuously or at least daily using calibrated recording devices. Logs are maintained per facility retention policy. When parameters are exceeded, a documented response is initiated: identifying root cause (HVAC failure, door sealing issue), assessing potentially affected sterile inventory, and notifying facilities management for corrective action.
Temperature and humidity are not monitored in sterile storage, or monitoring logs have gaps of more than 48 hours with no documented explanation.
Operations & Finance
Case cart accuracy — the percentage of carts delivered to the OR with all correct instruments, supplies, and implants — directly impacts OR on-time starts, surgical case efficiency, and flash sterilization rates. An inaccurate case cart creates a cascade: missing items require emergency processing, OR staff lose trust in SPD, and case start times slip — each OR minute of delay costs $60–120 in direct and indirect costs.
Case cart accuracy is tracked as a formal quality metric, measured by OR feedback data and SPD outgoing verification steps. Accuracy target is typically ≥98%. Inaccurate carts are documented by item type, case type, and time of day to identify patterns. Root causes (outdated preference cards, missing instruments, restocking gaps) are addressed systematically, not case-by-case.
Case cart accuracy is tracked only when the OR calls to complain — no proactive outgoing verification step exists and no accuracy rate data is available.
SPD managers increasingly compete for capital budget alongside high-visibility clinical departments. Without a structured ROI framework, SPD capital requests are often deprioritized — leaving the department operating aging equipment that drives inefficiency, compliance risk, and staff frustration. The CHL competency framework specifically requires that SPD leaders can build and defend financial justification for capital investments using healthcare-standard financial language.
Capital requests include a fully-loaded ROI analysis: current cost baseline (repair costs, overtime, downtime-related case delays, compliance risk), projected savings from the new equipment (throughput improvement, labor reduction, reduced maintenance), total cost of ownership (purchase + installation + training + service contracts), and payback period calculation. The request quantifies risk reduction (infection liability, regulatory exposure) in addition to operational savings.
Capital requests are submitted with only a vendor quote and a statement that "equipment is old" — without data on current costs, projected savings, or a payback period calculation.
Ready to Master Every Question?
SterileProtocol is the AI-powered certification prep and compliance training platform built exclusively for sterile processing professionals. Practice CIS, CER, CHL, CRCST, and CSPDT questions with adaptive spaced repetition — and track your domain mastery in real time.
Start Your Free Trial →Start your free trial at sterileprotocol.polsia.app